DAC
GCVRZ

Dividend Assets Capital’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Dividend Assets Capital’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-250
Closed – – 173
2014
Q3 		$0 Buy
+250
New +$121 ﹤0.01% 173
2014
Q2 		– Sell
-250
Closed – – 158
2014
Q1 		$0 Hold
250
– – ﹤0.01% 149
2013
Q4 		$0 Hold
250
– – ﹤0.01% 150
2013
Q3 		$1K Hold
250
– – ﹤0.01% 141
2013
Q2 		$0 Buy
+250
New +$439 ﹤0.01% 142

Other funds holding GCVRZ

WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
MCM
Mason Capital Management New York $613M AUM 21.43% 1-Year Est. Return
CPM
Chesapeake Partners Management Baltimore, Maryland $669M AUM 1.23% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
GCM
Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return

Dividend Assets Capital's GCVRZ Position: Q4 2014 in Review

Dividend Assets Capital sold out of Sanofi Contingent Value Rights (GCVRZ) in Q4 2014, closing a stake of 250 shares.

Dividend Assets Capital first reported a position in GCVRZ in Q2 2013 and held it in 5 quarters. The position peaked at $1K in Q3 2013. 118 funds tracked by Wall St. Rank hold GCVRZ as of Q4 2014.

  • Dividend Assets Capital reported no remaining Sanofi Contingent Value Rights position as of Q4 2014 after selling out during the quarter.
  • Dividend Assets Capital sold 250 Sanofi Contingent Value Rights shares in Q4 2014.
  • Dividend Assets Capital first reported a position in Sanofi Contingent Value Rights in Q2 2013 and held it in 5 quarters.
  • Dividend Assets Capital's Sanofi Contingent Value Rights position peaked at $1K in Q3 2013.
  • 118 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q4 2014.

Based on Dividend Assets Capital's 13F filing for Q4 2014, filed 6 Feb 2015.